Literature DB >> 7916034

Class and subclass distribution of Hantavirus-specific serum antibodies at different times after the onset of nephropathia epidemica.

J Groen1, M Gerding, J G Jordans, J P Clement, A D Osterhaus.   

Abstract

Sera from Dutch and Belgium individuals who suffered from nephropathia epidemica (NE), a mild form of haemorrhagic fever with renal syndrome (HFRS), were tested for the distribution of classes and subclasses of Hantavirus (HV)-specific antibodies at different times after the onset of the disease, with class- and subclass-specific Ig capture enzyme-linked immunosorbent assays (ELISAs). In the acute, early convalescent, and convalescent phases, predominantly specific IgA, IgM, and IgG3 antibodies were detected. Specific IgG2 antibodies were only detected at low levels in the early convalescent and convalescent phases. In the late convalescent phase specific IgG1 and IgG3 antibodies were found, whereas in the late postconvalescent phase only specific IgG1 antibodies proved to be present. Specific IgG4 antibodies were not detected in any of the respective phases. These data show that the simultaneous determination of classes and subclasses of HV specific serum antibodies allows the estimation of the time elapsed after the onset of NE.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916034     DOI: 10.1002/jmv.1890430108

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins.

Authors:  Helga Meisel; Anne Wolbert; Ausra Razanskiene; Andreas Marg; Andris Kazaks; Kestutis Sasnauskas; Georg Pauli; Rainer Ulrich; Detlev H Krüger
Journal:  Clin Vaccine Immunol       Date:  2006-10-04

2.  Specific humoral reaction of hemorrhagic fever with renal syndrome (HFRS) patients in China to recombinant nucleocapsid proteins from European hantaviruses.

Authors:  H-R Xiong; Q Li; W Chen; D-Y Liu; J-X Ling; J Liu; Y-J Liu; Y Zhang; Z-Q Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-08       Impact factor: 3.267

Review 3.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

4.  Recent advances in hantavirus molecular biology and disease.

Authors:  Islam T M Hussein; Abdul Haseeb; Absarul Haque; Mohammad A Mir
Journal:  Adv Appl Microbiol       Date:  2011       Impact factor: 5.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.